| IZBA 30 micrograms/mL eye drops, solution EU/1/13/905/001-002 |
Travoprost |
Novartis Europharm Limited |
— |
| Jakavi EU/1/12/773/001 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi EU/1/12/773/002 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi 10 mg tablets EU/1/12/773/013-016 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi 20 mg tablets EU/1/12/773/003 |
Ruxolitinib |
Novartis Europharm Limited |
— |
| Jakavi 5 mg tablets EU/1/12/773/004-006 |
Ruxolitinib phosphate |
Novartis Europharm Limited |
— |
| Jakavi 5mg/ml Oral solution EU/1/12/773/017 |
Ruxolitinib phosphate |
Novartis Europharm Limited |
— |
| Jalra 50 mg tablets EU/1/08/485/1-11 |
Vildagliptin |
Novartis Europharm Limited |
— |
| Kesimpta 20 mg solution for injection in pre-filled pen EU/1/21/1532/003-004 |
Ofatumumab |
Novartis Europharm Limited |
— |
| Kesimpta 20 mg solution for injection in pre-filled syringe EU/1/21/1532/001-002 |
Ofatumumab |
Novartis Europharm Limited |
— |
| Kisqali 200 mg film-coated tablets EU/1/17/1221/001-012 |
Ribociclib |
Novartis Europharm Limited |
— |
| Kymriah 1.2 × 106 – 6 × 108 cells dispersion for infusion EU/1/18/1297/001 |
AUTOGLAS T CELLS TRANSDUCED WITH LENTIVIRAL VECTOR CONTAINING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST CD1 |
Novartis Europharm Limited |
— |
| Lamisil 250 mg tablets PA0896/015/001 |
Terbinafine |
Novartis Ireland Limited |
Not marketed |
| Leqvio 284 mg solution for injection in pre-filled syringe EU/1/20/1494/001 |
Inclisiran |
Novartis Europharm Limited |
— |
| Lioresal 10 mg Tablets PA0896/017/001 |
Baclofen |
Novartis Ireland Limited |
Marketed |
| Lioresal 5mg/5ml Oral solution PA0896/017/002 |
Baclofen |
Novartis Ireland Limited |
Marketed |
| Lucentis 10 mg/ml solution for injection EU/1/06/374/002-004 |
Ranibizumab |
Novartis Europharm Limited |
— |
| Luxturna 5 × 1012 vector genomes/mL concentrate and solvent for solution for injection EU/1/18/1331/001 |
VORETIGENE NEPARVOVEC |
Novartis Ireland Limited |
— |
| Maxidex 0.1% w/v Eye Drops, Suspension PA0896/018/001 |
Dexamethasone |
Novartis Ireland Limited |
Marketed |
| Maxitrol 0.1% w/v, 6000 IU/ml, 3500 IU/ml eye drops, suspension PA0896/019/001 |
Dexamethasone, Polymyxin b sulfate, Neomycin sulfate |
Novartis Ireland Limited |
Not marketed |
| Mayzent 0.25 mg film-coated tablets EU/1/19/1414/001-002 |
Siponomid, SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| Mayzent 1 mg film-coated tablets EU/1/19/1414/007-008 |
SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| Mayzent 2 mg film-coated tablets EU/1/19/1414/003 |
Siponomid, SIPONIMOD FUMARIC ACID |
Novartis Europharm Limited |
— |
| Mekinist 0.5 mg film-coated tablets EU/1/14/931/01-02 |
Trametinib |
Novartis Europharm Limited |
— |
| Mekinist 1 mg film-coated tablets EU/1/14/931/03-04 |
Trametinib |
Novartis Europharm Limited |
— |
| Mekinist 2 mg film-coated tablets EU/1/14/931/05-06 |
Trametinib |
Novartis Europharm Limited |
— |
| Myfortic 180 mg gastro-resistant tablets PA0896/023/001 |
Mycophenolic acid |
Novartis Ireland Limited |
Marketed |
| Myfortic 360 mg gastro-resistant tablets PA0896/023/002 |
Mycophenolic acid |
Novartis Ireland Limited |
Marketed |
| Neoral 100 mg/ml concentrate for oral solution PA0896/024/004 |
Ciclosporin |
Novartis Ireland Limited |
Marketed |
| Neoral 100mg Soft Capsules PA0896/024/003 |
Ciclosporin |
Novartis Ireland Limited |
Marketed |
| Neoral 25 mg Soft Capsules PA0896/024/001 |
Ciclosporin |
Novartis Ireland Limited |
Marketed |
| Neoral 50mg Soft Capsules PA0896/024/002 |
Ciclosporin |
Novartis Ireland Limited |
Marketed |
| Neparvis 15 mg/16 mg granules in capsules for opening EU/1/16/1103/019 |
Sacubitril, Valsartan |
Novartis Europharm Limited |
— |
| Neparvis 24 mg/26 mg film-coated tablets EU/1/16/1103/001 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Neparvis 49 mg/51 mg film-coated tablets EU/1/16/1103/002-004 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Neparvis 6 mg/6 mg granules in capsules for opening EU/1/16/1103/018 |
Sacubitril, Valsartan |
Novartis Europharm Limited |
— |
| Neparvis 97 mg/103 mg film-coated tablets EU/1/16/1103/005-007 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Nevanac 1 mg/ml Eye drops, suspension EU/1/07/433/001 |
Nepafenac |
Novartis Europharm Limited |
— |
| Nevanac 3 mg/ml Eye drops, suspension EU/1/07/433/002 |
Nepafenac |
Novartis Europharm Limited |
— |
| Onbrez Breezhaler 150 microgram inhalation powder, hard capsules EU/1/09/593/1-5 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Onbrez Breezhaler 300 microgram inhalation powder, hard capsules EU/1/09/593/6-10 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Opatanol EU/1/02/217/002 |
Olopatadine hydrochloride |
Novartis Europharm Limited |
— |
| Opatanol 1 mg/mL eye drops, solution EU/1/02/217/001 |
Olopatadine hydrochloride |
Novartis Europharm Limited |
— |
| Oslif Breezhaler 150 microgram inhalation powder, hard capsules EU/1/09/586/1-5 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Oslif Breezhaler 300 microgram inhalation powder, hard capsules EU/1/09/586/6-10 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Piqray 150 mg film-coated tablets EU/1/20/1455/001-003 |
Alpelisib |
Novartis Europharm Limited |
— |
| Piqray 200 mg film-coated tablets EU/1/20/1455/007-009 |
Alpelisib |
Novartis Europharm Limited |
— |
| Piqray 50 mg film-coated tablets Piqray 200 mg film-coated tablets EU/1/20/1455/004-006 |
Alpelisib |
Novartis Europharm Limited |
— |
| Revolade 12.5 mg film-coated tablets EU/1/10/612/010-012 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |
| Revolade 25 mg film-coated tablets EU/1/10/612/1-3 |
Eltrombopag olamine |
Novartis Europharm Limited |
— |